SCARNA10

Across TCGA pan-cancer cohorts, SCARNA10 RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated SCARNA10 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher SCARNA10 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated SCARNA10 expression acts as an unfavorable survival marker, although some lineages such as CESC and LUSC show a favorable association.

KIRC, ACC, and MESO are the cancer types where SCARNA10 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Quartile	All	0.526	0.703	<.001	120	view →
ACC	OS	Median	IV	0.384	0.872	<.001	66	view →
MESO	OS	Quartile	III,IV	0.372	0.756	.001	58	view →
CESC	OS	Tertile	III,IV	0.830	0.480	.012	46	view →
LUSC	OS	Median	All	0.460	0.348	.003	38	view →
LUAD	DFS	Median	IV	0.690	0.314	.002	33	view →
UCS	DFS	Median	III,IV	0.157	0.479	.026	12	view →
GBM	DFS	Median	All	0.242	0.161	.016	9	view →
SARC	DFS	Quartile	All	0.417	0.635	.004	8	view →
THYM	OS	Median	All	1.000	0.732	.028	7	view →
COAD	OS	Median	All	0.920	0.822	.032	6	view →
STAD	OS	Quartile	IV	0.575	0.197	.017	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 22 lineages.

SCARNA10–KIRC (DFS)

Open the KIRC breakdown →